Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140030/S025

Astron Peripheral Self-Expanding Nitinol Stent System

Biotronik AG · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONP140030/S025

What did the FDA decide?

The FDA database lists decision OK30 on 2026-09-11 for P140030/S025, a 30-Day Notice supplement to the Astron Peripheral Self-Expanding Nitinol Stent System PMA (P140030). The applicant is Biotronik AG, and the supplement reason is recorded as a process change affecting manufacturer, sterilizer, packager or supplier, with device category STENT, ILIAC and product code NIO.

The stated scope is modifications to the Gold-plating manufacturing equipment. The record does not identify which equipment, what the modification was, or how it relates to stent production, so those specifics remain unknown. The S025 identifier ties the filing to the existing P140030 PMA rather than a new system approval, and the stated purpose of the notice is not independent evidence of safety or clinical effectiveness.

The decision code OK30 and the September 2026 date are as recorded in the supplied database fields; the entry provides no further rationale, review detail or outcome description beyond that code and date.

FDA approval order statement

modifications to the Gold-plating manufacturing equipment
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 11, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140030/S025
Regulatory pathway
PMA supplement
Applicant
Biotronik AG
Product code
NIO
Decision code
OK30
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Applicant
Biotronik AG
Product code
NIO
FDA device class
3

For the original device and its historical approval scope, see PMA P140030. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140030 · Original PMA

    ASTRON PERIPHERAL SELF-EXPANDING NITINOL STENT SYSTEM

  2. P140030/S025 received

    Application receipt date recorded by FDA.

  3. P140030/S025 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140030

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik AGPMA approvalDec 17, 2015FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA
Medtronic Vascular, Inc.PMA approvalJun 8, 2004FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ackerstrasse 6, Bülach, 8180

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records